News in the Life Sciences Industry

UPPSALA, Sweden, Sept. 10, 2019 /PRNewswire/ -- Beactica Therapeutics, the Swedish drug discovery company, today announced the appointment of a Head of Preclinical Development, two new members of the Board, and a clinical advisor. The appointments are made to strengthen the organisation as the... Read more ››

STOCKHOLM, Sept. 9, 2019 /PRNewswire/ -- A feasibility study performed as a Master Thesis at Uppsala University and supervised by Diamyd Medical, supports the use of ultrasound guided intralymphatic injections for clinical routine use. This pilot study is based on interviews with and answers... Read more ››

100th Leksell Gamma Knife Icon begins operations at Kaunos Klinikos

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume... Read more ››

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the list of shareholders has been updated on the homepage with information as of August 30, 2019.

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Heidelberg University Hospital, Germany, has treated its first patient using Monte Carlo photon dose planning in RayStation®*. The decision to go clinical was made after a thorough validation of the functionality. The first patient, who has cervical... Read more ››

STOCKHOLM, Sept. 4, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotechnology company in autoimmune diseases, today announced that the company's board of directors has decided to explore the possibilities of an orphan drug designation (ODD) of the drug candidate Rabeximod. An orphan drug... Read more ››

STOCKHOLM, Sept. 4, 2019 /PRNewswire/ -- Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has entered an exclusive distribution agreement for selling the all-new Ironhand® with ITURRI, SA. Group for the German, Spanish, Portuguese and Polish market. ITURRI has a management team... Read more ››

STOCKHOLM, Sept. 4, 2019 /PRNewswire/ -- Preliminary results show that Enzymatica's prospective, randomized, double-blinded multicenter study did not meet the primary end-point "Significant improvement of quality of life during treatment with ColdZyme compared to placebo in common cold".... Read more ››

STOCKHOLM, Sept. 4, 2019 /PRNewswire/ -- Cantargia AB today announced that a request for a pre-IND meeting with the US FDA has been submitted. The purpose of the meeting is to discuss the current documentation on the antibody CAN04 and a proposed new phase I clinical combination study with... Read more ››

STOCKHOLM, Sept. 3, 2019 /PRNewswire/ -- SciBase today announces the first sale and shipment of SciBase products for the evaluation of skin barrier function. The first shipment is to a prestigious hospital in Japan for research into skin barrier function in infants.